HSHHSH Health Technology Supplier Hub
Home › Suppliers › B. Braun › Risk

B. Braun: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Oct 2026: B. Braun said it will close its US unit B. Braun Interventional Systems, with sales continuing to 31 Mar 2027, to streamline operations; it reported no immediate supply disruption and said its global interventional vascular business is unaffected.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving B. Braun found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Jan 2026: B. Braun Medical Inc. began a Class 2 US recall of one lot of a spinal epidural catheter kit after its supplier recalled the liquid adhesive included in the kit, whose tubing may crack and make it unusable.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

No notable go-lives, troubled implementations, terminations or customer disputes involving B. Braun found in HSH's search of the last 24 months.

Researched 10 Nov 2026